UK Medicine Shortages in 2026: What Is Driving Them and What Pharmacies Can Do
Medicine shortages have become a daily reality for UK pharmacy teams. In June 2026 the National Pharmacy Association and the Royal College of GPs warned that current shortages are among the most severe the UK has experienced, and that some now rank as the longest-running shortages of individual medicines in NHS history.
The scale of the problem
A National Pharmacy Association survey in June 2026 found that almost all responding pharmacies saw a serious risk to patient safety, and the large majority were unable to dispense at least one medicine every day. Even common products such as aspirin, co-codamol and ramipril have been affected this year, according to the Royal Pharmaceutical Society.
What is behind it
Global supply chains: a House of Lords committee reported in February 2026 that most active ingredients used in NHS medicines come from China, India or other single sources.
Low prices: years of downward pressure on generic prices have reduced the incentive for manufacturers to invest in resilient supply to the UK.
Manufacturing and quality problems at individual plants, which can affect a product worldwide.
Rising demand for some therapy areas, which outpaces manufacturing capacity.
What pharmacies can do now
Keep a second, and even a third, wholesale account for hard-to-find lines.
Check Serious Shortage Protocols regularly, because they are time-limited and product-specific.
Talk to prescribers early about suitable alternatives.
Give patients honest information about when stock is expected.
Looking ahead
The House of Lords committee called for medicines shortages to be treated as a national security issue. Until structural changes arrive, resilience comes down to strong supplier relationships. Acorn Pharmaceuticals helps UK pharmacies find stock when their usual channels run dry.
Talk to Acorn Pharmaceuticals: email gb@acornpharmaceuticals.co.uk or message us on WhatsApp.
Comments